Better Buy: Celgene Corporation vs. Bristol-Myers Squibb

Better Buy: Celgene Corporation vs. Bristol-Myers Squibb


My colleague Sean Williams included both stocks in his list of four top drug stocks that can be purchased on the cheap this fall. David Liang pointed to Celgene and Bristol as two "beaten-up blue-chip biotech stocks" to buy on sale.



from Biotech News